Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Z0HS
|
|||
Former ID |
DIB009575
|
|||
Drug Name |
Hu Dreg 55
|
|||
Synonyms |
SMART Anti-L-Selectin
Click to Show/Hide
|
|||
Drug Type |
Antibody
|
|||
Indication | Psoriasis vulgaris [ICD-11: EA90; ICD-9: 696] | Terminated | [1] | |
Company |
PDL BioPharma
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | L-selectin (SELL) | Target Info | . | [2] |
KEGG Pathway | Cell adhesion molecules (CAMs) | |||
NetPath Pathway | IL9 Signaling Pathway | |||
IL2 Signaling Pathway | ||||
Leptin Signaling Pathway | ||||
Reactome | Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | |||
Cell surface interactions at the vascular wall | ||||
WikiPathways | Human Complement System | |||
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | ||||
Cell surface interactions at the vascular wall |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004232) | |||
REF 2 | Clinical pipeline report, company report or official report of glycomimetics. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.